Company: GCTS
Filing Date: 2025-03-26
Form Type: 424B3
Source: 0000929638-25-001279
Chunk: 102

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-03-26
Form: 424B3
Chunk 102
---
 products, including masks, wafers and design house fees; • Acquisition of IP and tool enhancement to develop next generation of product; • Hiring of additional personnel in engineering and sales and marketing functions; and • Improvement of engineering equipment. While we believe that we have a reasonable basis for our expectation and we will be available to raise additional funds, we cannot provide assurance that we will be able to complete additional financing in a timely manner. In addition, the sale of additional equity securities could result in dilution to our stockholders. The incurrence of indebtedness would result in increased debt service obligations and may include operating and financial covenants that would restrict our operations. We cannot be certain that any financing will be available in the amounts we need or on terms acceptable to us, if at all. Should we enter into definitive collaboration and/or joint venture agreements or engage in business combinations in the future, we may be required to seek additional financing. Cash flow Comparison for the Years Ended December 31, 2024 and 2023 The following table summarizes our cash flows for the periods indicated (in thousands):

|                                                              |     | Year Ended December 31, |    2024 |   |     |   |   2023 |   |
|:-------------------------------------------------------------|:----|:------------------------|--------:|:--|:----|:--|-------:|:--|
| Net cash used in operating activities                        |     | $                       | (30,957 | ) |     | $ | (8,827 | ) |
| Net cash used in investing activities                        |     |                         |    (542 | ) |     |   |   (331 | ) |
| Net cash provided by financing activities                    |     |                         |  36,473 |   |     |   |  8,149 |   |
| Effect of exchange rate changes on cash and cash equivalents |     |                         |  (3,797 | ) |     |   |   (131 | ) |
| Net increase (decrease) in                                   
 cash and cash equivalents                                    |     | $                       |   1,177 |   |     | $ | (1,140 | ) |

Operating Activities Cash used in operating activities of $31.0 million during the year ended December 31, 2024 was primarily attributable to our net loss of $12.4 million, non-cash adjustments of $9.7 million, and a net change in our operating assets and liabilities of $8